Secondary prevention in patients with coronary artery disease in Russia and Europe: results from the Russian part of the EUROASPIRE V survey

Secondary prevention in patients with coronary artery disease in Russia and Europe: results from the Russian part of the EUROASPIRE V survey

Aim. To assess the secondary prevention in Russian patients with coronary artery disease in the long-term period after acute myocardial infarction, acute coronary syndrome (ACS), percutaneous coronary intervention and/or coronary artery bypass grafting, obtained in the European Action on Secondary a...

Full description

Bibliographic Details
Main Authors:	N. V. Pogosova, R. G. Oganov, S. A. Boytsov, A. K. Ausheva, O. Yu. Sokolova, A. A. Kursakov, I. V. Osipova, O. N. Antropova, Yu. M. Pozdnyakov, A. O. Salbieva, I. N. Lelchuk, T. A. Gusarova, N. V. Gomyranova, N. A. Skazin, K. Kotseva
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2020-12-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	ишемическая болезнь сердца вторичная профилактика факторы риска целевые уровни
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2739

Similar Items

Hypolipidemic effectiveness and safety of generic lovastatin
by: D. M. Aronov, et al.
Published: (2006-12-01)

Comparison of medicamental secondary prevention of cardiovascular disease in ambulatory patients with myocardial infarction over a period of 2001-2006 (pharmacoepidemiological study)
by: S B Fitilev, et al.
Published: (2009-03-01)

PSYCHOSOCIAL FACTORS AND LIFE QUALITY IN CORONARY HEART DISEASE PATIENTS: RESULTS OF THE RUSSIAN PART OF INTERNATIONAL MULTICENTER STUDY EUROASPIRE IV
by: N. V. Pogosova, et al.
Published: (2017-10-01)

Arterial hypertension and coronary heart disease treatment compliance – a key factor in cardiovascular mortality reduction
by: G. V. Pogosova, et al.
Published: (2007-02-01)

Secondary prevention of coronary heart disease in Moscow-population patients with myocardial infarction
by: R. G. Oganov, et al.
Published: (2005-06-01)

Statinotherapy – the paradigm of prevention and treatment of atherosclerotic pathology (focus on atorvastatin)
by: R. G. Oganov, et al.
Published: (2006-12-01)

Secondary prevention of coronary heart disease in clinical practice: choosing the treatment
by: M. G. Bubnova
Published: (2009-08-01)

Could secondary prevention of coronary heart disease be more effective?
by: V. I. Makolkin
Published: (2010-02-01)

Barriers for statin prescription in real-world clinical practice (results of a survey among Krasnodar City and Krasnodar Region doctors)
by: V. V. Skibitsky, et al.
Published: (2008-06-01)

Physical activity assessment in coronary heart disease patients: questionnaire ODA-23+
by: V. B. Krasnitskyi, et al.
Published: (1970-01-01)

SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE
by: E. V. Filippov, et al.
Published: (2015-12-01)

Clinical effects of statins: focusing on simvastatin
by: D. M. Aronov, et al.
Published: (2009-04-01)

FREQUENCY OF OCCURRENCE OF RISK FACTORS AND ADHERENCE TO DRUG THERAPY IN YAKUTS WHO UNDERWENT Q-POSITIVE MYOCARDIAL INFARCTION
by: E. S. Kylbanova, et al.
Published: (2018-08-01)

Long-term effectiveness of secondary prevention in patients with acute coronary syndrome
by: I. B. Ryzhikova, et al.
Published: (1970-01-01)

Clinical characteristics of stable angina patients and their treatment strategies in real-world clinical practice. A Russian PERSPECTIVE Study (Part I)
by: M. G. Bubnova, et al.
Published: (2010-12-01)

Assessing the implementation of the recommendations on secondary cardiovascular prevention in patients after myocardial infarction (a pharmaco-epidemiologic study)
by: R. G. Oganov, et al.
Published: (2009-08-01)

Problems of selecting an anticoagulant for secondary stroke prevention in patients with atrial fibrillation
by: V. V. Gusev, et al.
Published: (2021-10-01)

Relevant problems of participation and education of patients in cardiac rehabilitation and secondary prevention programs
by: M. G. Bubnova
Published: (2020-12-01)

Secondary prevention of myocardial infarction: effectiveness assessment in primary healthcare settings
by: Yu. I. Nesterov, et al.
Published: (2010-10-01)

EVALUATION OF LONGTERM OUTCOMES AFTER STROKE: RESULTS OF THE LIS-2 REGISTRY
by: C. Yu. Martsevich, et al.
Published: (2015-12-01)

MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH PERSISTENT ST-SEGMENT ELEVATION
by: Frans Van de Werf, et al.
Published: (2016-01-01)

PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION
by: N. V. Mikheeva, et al.
Published: (2015-09-01)

Acetylsalicylic acid as an anti-platelet agent: what forms should be used, according to evidence-based medicine?
by: O. V. Averkov
Published: (2010-04-01)

CURRENT VIEWS ON ANTITHROMBOTIC THERAPY IN NON-CARDIOEMBOLIC STROKE
by: A. V. Fonyakin, et al.
Published: (2017-05-01)

Double cholesterol inhibition — a new approach to effective control of hyperlipidemia and atherosclerosis
by: A. V. Susekov, et al.
Published: (2009-12-01)

ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF STROKE
by: P. S. Laguta
Published: (2017-05-01)

Health School effectiveness in patients with chronic heart failure: gender differences
by: M. V. Malishevsky, et al.
Published: (2010-06-01)

CHARACTERISTICS OF PATIENTS WITH CEREBRAL STROKE OR TRANSIENT ISCHEMIC ATTACK, INCLUDED INTO THE LIS-2 REGISTER (LYUBERTSY STUDY OF MORTALITY IN PATIENTS AFTER STROKE)
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

Secondary prevention effectiveness in patients with stable angina
by: Rasim Kutlu, et al.
Published: (2010-08-01)

STUDY OF THE PHYSICIAN RECOMMENDATION ADHERENCE IN PATIENTS AFTER STROKE. THE ROLE OF ANXIETY AND DEPRESSION (REGISTRY LIS-2)
by: N. Yu. Zhuravskaya, et al.
Published: (2015-04-01)

The results of implementation of specialized stroke units and educational programs aimed at the secondary prevention of stroke in Tyumen district
by: D. I. Lebedeva, et al.
Published: (2019-03-01)

EVALUATION OF THE CONFORMITY OF CARDIOVASCULAR THERAPY TO CURRENT CLINICAL GUIDELINES IN THE IMPROVEMENT OF OUTCOMES IN PATIENTS AFTER STROKE (ACCORDING TO THE LIS-2 REGISTER)
by: A. Yu. Suvorov, et al.
Published: (2015-09-01)

THE WAY OF ASSESSING THE ADHERENCE TO MODERN DRUG THERAPY CLINICAL GUIDELINES AIMED AT REDUCING THE RISK OF RECURRENT STROKE (ACCORDING TO THE LIS-2 REGISTER)
by: A. Yu. Suvorov, et al.
Published: (2015-09-01)

Potential and methods of target cholesterol level achievement in daily clinical practice: results of the Russian multi-centre observational study “TREAT TO GOAL”
by: V. O. Konstantinov
Published: (2011-04-01)

EVALUATION OF OPTIMAL HIGH DENSITY CHOLESTEROL VALUE IN COHORT OF ALMOST HEALTHY MEN 40-59 YEARS OLD (BY THE DATA OF 30-YEAR PROSPECTIVE OBSERVATION)
by: V. V. Belov, et al.
Published: (2015-06-01)

Healthy nutrition in secondary prevention after myocardial infarction. What to focus on?
by: O. L. Barbarash, et al.
Published: (2022-01-01)

Comorbidities in clinical practice. Algorithms for diagnostics and treatment
by: R. G. Oganov, et al.
Published: (2019-03-01)

COMORBIDITIES IN PRACTICE. CLINICAL GUIDELINES
by: R. G. Oganov, et al.
Published: (2017-12-01)

New perspectives in improving prognosis after myocardial infarction
by: N. M. Akhmedzhanov
Published: (2006-06-01)

Anticoagulant therapy for the prevention of recurrent stroke in patients with atrial fibrillation: a comprehensive risk management
by: V. A. Sorokoumov
Published: (2022-01-01)